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Li Shang1, Karin Nienhaus1 and Gerd Ulrich Nienhaus1,2,3*Abstract
With the rapid advancement of nanoscience and nanotechnology, detailed knowledge of interactions between
engineered nanomaterials and cells, tissues and organisms has become increasingly important, especially in regard
to possible hazards to human health. This review intends to give an overview of current research on nano-bio
interactions, with a focus on the effects of NP size on their interactions with live cells. We summarize common
techniques to characterize NP size, highlight recent work on the impact of NP size on active and passive cellular
internalization and intracellular localization. Cytotoxic effects are also discussed.
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In recent years, nanoparticles (NPs) and other nanoma-
terials have entered essentially all areas of our everyday
lives. In industrial applications, they have become indis-
pensable components of catalysts [1], sensors [2] or
photovoltaic devices [3]. In the biomedical field, they
have found wide-spread use as nanovaccines [4], nano-
drugs [5] and diagnostic imaging tools [6]. However, our
knowledge about biological effects and, importantly, po-
tential risks of the omnipresent (intended and unin-
tended) exposure to nanomaterials has not kept up with
the pace of these developments and is still very limited
[7,8].
NPs may invade the human body via inhalation, ingestion
or through the skin (Figure 1). Once they have entered a
biological milieu, NPs will inevitably come into contact with
a huge variety of biomolecules including proteins, sugars
and lipids that are dissolved in body fluids, such as the
interstitial fluid between cells, lymph or blood. These bio-
molecules immediately coat the NP surfaces and form the
so-called ‘protein corona’ [9-11], which determines the bio-
logical identity of the NP [12]. Its composition is dynamic* Correspondence: uli.nienhaus@kit.edu
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stated.and depends on the relative concentrations of the individ-
ual components and on their affinities toward the NP sur-
face. In fact, NPs have to be viewed as evolving systems
that adapt to varying concentrations of the biomolecules
present in the fluid. It has been suggested that the ‘final cor-
ona’ reflects its own prior history [13].
NPs have to surmount the cell membrane to intrude
cells. One of the hallmarks of any cell membrane is its abil-
ity to selectively control the flow of ions and molecules into
and out of the cell, and to maintain a separation between
the cytosol and the extracellular environment. Large
macromolecular agglomerates, e.g., protein assemblies, lipo-
protein particles, viruses and also NPs are typically encap-
sulated in vesicles and selectively transported into and out
of the cells via endocytosis and exocytosis, respectively
(Figure 1). Different types of endocytosis mechanisms are
known, varying with the size of the transport vesicle, cargo
properties and the internalization machinery involved. In
most cells, internalization occurs via pinocytosis. In this
process, an invagination forms in the cell membrane that is
finally pinched off so as to generate a vesicle in the cyto-
plasm that contains the internalized materials. Typically,
the inward budding vesicles contain receptor proteins that
recognize specific chemical groups on the molecules to be
internalized. Thus, if proteins adsorbed to an NP trigger cell
surface receptors, they will readily activate the cell’s uptake
machinery, whereas adsorbed proteins that only weakly
interact with membrane-associated biomolecules will re-
duce the uptake of the ‘disguised’ NPs. Specialized cells, so-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Nanoparticle uptake. NPs may enter the human body via inhalation, ingestion or through the skin. In the extracellular fluid, NPs are
coated by proteins and other biomolecules. The so-called protein corona determines how the NP interacts with a cell. Cellular internalization may
involve active (receptor-mediated) or passive transport across the cell membrane.
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trophils, and monocytes are capable of phagocytosis, a form
of endocytosis in which the cell engulfs larger particles. In
addition to intruding cells by active transport, NPs may also
enter cells by passive penetration of the cell membrane. In
fact, for cells lacking the endocytosis machinery such as red
blood cells (RBCs), passive transport is the only option.
Regardless of the specific internalization mechanism,
the cell-NP interactions are, on the one hand, modulated
by physicochemical properties of the NPs including size,
shape, surface charge and surface chemistry [14] and, on
the other hand, by cell-specific parameters such as cell
type or cell cycle phase [15]. The uptake efficiency might
even be affected by specific properties of the experimen-
tal setup [16]. A quantitative understanding of the NP-
biomolecule/membrane interaction is, therefore, an im-
portant prerequisite for designing and engineering NPs
with intentionally enhanced or suppressed cellular up-
take [17,18]. In the present review, we shall focus mainly
on the effect of NP size on the interaction with live cells.
We present a survey of methods to determine the size of
NPs, investigate the impact of the NP size on active and
passive uptake and discuss their cytotoxic effects.
Characterization of the NP size in biological media
To correlate a particular physicochemical property of a
NP with biological responses and to ensure that these
results are reproducible and meaningful, an accurate
characterization of the NP is essential. NP size is a keyparameter (in the following, particle size always refers to
the diameter). Many NPs are composed of a ‘heavy’ core
(e.g., a metal or semiconductor nanocrystal) surrounded
by small organic ligands to ensure colloidal stability.
Electron microscopy techniques such as transmission
electron microscopy (TEM) can easily provide accurate
size measurements with sub-nanometer resolution.
However, organic surface ligands are difficult to resolve
owing to their low electron density, so the TEM-
determined size mainly reflects the size of the core. In
addition, the requirement of high vacuum for TEM im-
aging calls for complicated sample preparation proce-
dures that can result in NP aggregation [19]. Dynamic
light scattering (DLS) is a widely used technique for NP
size determination in suspension. DLS is based on scat-
tering intensity fluctuations due to Brownian motion of
NPs in suspension and relates the diffusion coefficient to
the size via the Stokes–Einstein equation. The measured
hydrodynamic diameter reflects the dimension of the NP
(core plus shell) together with layer of surface-bound
solvent. DLS provides a simple and speedy measurement
of NP size in biological media. However, the method suf-
fers from low sensitivity toward small particles and pos-
sible interference from light-absorbing species [20].
Fluorescence correlation spectroscopy (FCS) is a sensi-
tive technique capable of measuring the hydrodynamic
diameter of freely diffusing NPs, if these are either in-
trinsically fluorescent or have been labeled with fluores-
cent dyes [9]. The FCS method is based on the analysis
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ual NPs passing through a tiny focal volume of typically
1 fL (10–15 l), from which the NP size can be calculated
via autocorrelation analysis [21,22]. As with DLS, the
size information comprises both the core and the ligand
layer. Other techniques to determine NP size include
nanoparticle tracking analysis (NTA) [23], atomic force
microscopy (AFM) [24], absorption spectroscopy [25]
and analytical ultracentrifugation [26]. Advantages as
well as limitations of the different techniques are sum-
marized in Table 1.
One should be aware that NP preparations are often
polydisperse. The DLS technique directly provides the
size distribution information. Still, one has to be careful
when interpreting the data because DLS is based on
density-density correlations and, therefore, the intensity
scales with the sixth power of the NP diameter. Caution
is advised when dealing with samples containing parti-
cles of markedly different sizes. Size distributions may
also be quantified by using AFM. Such data have been
proposed to be more accurate than those obtained via
DLS [27]. TEM image analysis suffers from limited sam-
pling, so that the selected NPs may not be representative
of the whole sample. Overall, it is advisable to apply dif-
ferent methods to ensure a robust size determination.
Independent of the technique chosen for size
characterization, the NPs should – if at all possible – be
suspended in the medium/solvent that will be used to
expose the NPs to the biological samples during such
measurements. The colloidal stability of NP suspensions
is influenced by many factors including the solution
ionic strength, pH and solvent composition. Because
NPs are often charge-stabilized, the colloidal stability of
NPs in pure water is significantly different from that in
biologically relevant media [28,29]. Particularly, one has
to be aware that biomolecules present in biological
media, such as proteins, will inevitably adsorb on the NP
surface [30-32], which leads to an increase in the hydro-
dynamic radius of the NP. In fact, the NP size may evenTable 1 Commonly used experimental techniques to characte
Technique Advantages
TEM Direct visualization, high resolution
DLS Size distribution information available, fast, simple
NTA Real time analysis, particle-by-particle measurement
FCS High sensitivity, small sample volume, particle-by-
particle measurement
AFM High size resolution, 3-D profile
Absorption spectra Simple, fast
Analytical
ultracentrifugation
Size distribution information available, high size
resolution
Abbreviations used: TEM transmission electron microscopy, DLS dynamic light scatte
spectroscopy, AFM atomic force microscopy.influence the characteristics of the protein corona
[33-36], such as thickness, composition and protein ac-
tivity, which may modulate their cellular interactions.
NP size effects on active cellular internalization
Endocytosis is a fundamental biological process used by
cells to internalize (bio)molecules and, because of their
similar size, also NPs [37,38]. It may involve the engage-
ment of either clathrin or caveolin pits, but may also be
independent of these proteins. As is apparent from the
studies listed in Table 2, NP size may affect the uptake
efficiency and kinetics, the internalization mechanism
and also the subcellular distribution. A size-dependent
uptake in different cell lines has been observed for Au
[29,39,40], mesoporous silica [41], polystyrene [42] and
iron oxide NPs [43], with the maximum cellular uptake
at a NP core size in the range of 30–50 nm, which sug-
gests that there is an optimal size for active uptake.
Hökstra et al. [59] used a range of fluorescent latex
beads of defined sizes (50 – 1,000 nm) to investigate the
effect of NP size on the entry pathway in non-
phagocytic B16 cells. Internalization of NPs <200 nm
was observed to involve clathrin-coated pits. With in-
creasing size, a shift towards caveolae-mediated internal-
ization became apparent, which turned out to be the
predominant entry route for 500-nm particles. Rafailo-
vich et al. [50] reported that 45-nm Au NPs penetrated
cells via clathrin-mediated endocytosis, while the smaller
13-nm NPs entered mostly via phagocytosis.
By using spinning disk confocal microscopy and quan-
titative image analysis, Nienhaus and coworkers have
systematically investigated the uptake of various NPs in
the range of 3.3 ‒ 100 nm by live HeLa cells. Interest-
ingly, QDs [60] and Au nanoclusters (AuNCs) [61,62]
with less than 10 nm diameter were found to accumulate
on the plasma membrane before gradually entering the
intracellular region (Figure 2). In stark contrast, large
polystyrene NPs (100 nm) were directly internalized
without detectable prior accumulation at the plasmarize NP size
Limitations
NP aggregation during sample preparation, electron beam damage,
preference for electron-dense atomic species
Signal dominated by larger NPs, interference from luminescent species
Suitable to a certain size range, interference from luminescent species
NPs need to be luminescent, sensitive to aggregates
Slow speed, limited scanning area
Applicable to plasmonic (Au, Ag) and semiconductor (CdSe, CdTe) NPs
Density of NPs needs to be known, long measurement time
ring, NTA nanoparticle tracking analysis, FCS fluorescence correlation
Table 2 Size dependence of active cellular NP uptake
NPs Size (nm Ø) Cell lines Techniques Main conclusions Ref.
Au 2–15 MCF-7 ICP-MS, TEM Higher uptake of smaller NPs; 2/6 nm locate in cytoplasm and
nucleus, 15 nm only in cytoplasm
[44]
QDs 2–7 A-427 FCS Size-dependent internalization efficiency [45]
Au 2.4–89 Cos 1 Silver staining, CLSM 2.4 nm: in nucleus; 5.5 and 8.2 nm: partially in cytoplasm; 16 nm
and above: no uptake
[46]
Au 2–100 SK-BR-3 CLSM 40/50 nm: greatest effect [47]
Au 4–17 HeLa AFM Uptake increases with NP size [48]
TiO2 5–80 A549 Light scattering μ-
Raman, TEM
Uptake depends on overall size (with hard corona) [49]
Iron
oxide
8–65 RAW264.7 ICP-AES 37 nm (HD 100 nm): highest uptake [43]
Au 10–50 NRK TEM, ICP-MS Uptake efficiency: 50 > 25 > 10 nm [44]
Au 13, 45 CF-31 TEM, SEM, CLSM 45 nm: clathrin-mediated endocytosis, 13 nm: mostly
phagocytosis
[50]
Au 14–100 HeLa ICP-AES, TEM 50 nm: maximum uptake [39]
Au 15–55 SK-BR-3 SEM, ICP-MS, Surface ligands affect size dependency [51]
Au 15–90 J774A.1 ICP-AES No significant size dependency [52]
Au 16–58 RAW 264.7, HepG2 ICP-MS, TEM Negatively charged: 40 nm highest uptake; positively charged:
no size-dependent uptake
[53]
Au 20–80 CHO-K1, HeLa, MCF-7 Flow cytometry,
ICP-AES, TEM,
Less internalization with increasing size [54]
PS 20–100 1321 N1, A549 CLSM, flow
cytometry
40 nm: fastest internalization rate [42]
MSN 30–280 HeLa CLSM, ICP-MS 50 nm: maximum uptake [41]
Au 30–90 PC3 TEM, ICP-MS 50 nm: maximum uptake [29]
SiO2 32, 83 Caco-2 CLSM 32 nm: enter nucleus, migrate faster [55]
PS 40–2000 HeLa, A549, 1321 N1, HCMEC
D3, RAW 264.7
CLSM, flow
cytometry
Uptake highly size-dependent for all cell lines, larger NPs enter
more slowly
[56]
Au 45–110 CL1-0, HeLa Scattering imaging 45 nm: maximum uptake [40]
polymer 50–300 Caco-2, HT-29 Deserno’s model,
CLSM
100 nm: maximum uptake [57]
polymer 150–500 L02, SMMC-7221 Fluorimetry Large NPs with high net charge: uptake more efficient [58]
Abbreviations used: ICP-MS inductively coupled plasma mass spectrometry, CLSM confocal laser scanning microscopy, ICP-AES inductively coupled plasma atomic
emission spectrometry, SEM scanning electron microscopy, MSN mesoporous silica nanoparticles.
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strated that, despite having the same size, ~100-nm car-
boxy (PS-COOH) and amino functionalized polystyrene
(PS-NH2) NPs were internalized by human macrophages
and by undifferentiated and PMA-differentiated mono-
cytic THP-1 cells via different mechanisms. Notably, the
mechanism did not only depend on the NP type and the
cell type, but also on the experimental conditions (buffer
or medium supplemented with human serum). They also
noticed that only the PS-NH2 NPs triggered NLRP3
inflammasome activation and subsequent release of pro-
inflammatory interleukin 1β (IL-1β) by human macro-
phages [66]. Hühn et al. [67] modified colloidal AuNPs
with amphiphilic polymers to obtain NPs with identical
physical properties except for the sign of the charge(negative/positive) and showed that the uptake rate by
cells was higher for positively than for negatively
charged NPs.
The size-dependent interaction of NPs with the cell
membrane is likely related to the membrane-wrapping
process that initiates receptor-mediated endocytosis. It
requires the concerted formation of multiple NP-
receptor interactions [68,69]. Small NPs have less
ligand-to-receptor interactions than larger ones; thus,
several small NPs need to interact simultaneously with
receptors in close proximity to trigger membrane wrap-
ping. In contrast, an individual, large NP can act as a
cross-linking agent to cluster receptors and induce up-
take. Mathematical modeling has demonstrated that
receptor-mediated endocytosis is optimal when there is
Figure 2 Active NP uptake. (a – d) Internalization of DPA-QDs (8 nm) by HeLa cells [60]. (e – h) Uptake of DHLA-AuNCs (3.3 nm) by HeLa cells
[61]. (i – l) Uptake of polystyrene NPs (100 nm, coated with carboxylic groups) by mesenchymal stem cells (MSCs) [63]. Reproduced with permis-
sion from the American Chemical Society and the Royal Chemical Society.
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shortage on the cell surface [70]. Thermodynamically, a
50 – 60 nm NP is capable of recruiting enough receptors
to successfully trigger internalization. The nature of the
protein corona, which is controlled by the NP surface li-
gands, may also affect the membrane response and,
thereby, modify the cellular responses toward the NPs
[52,71]. Considering that most uptake studies involving
live cells have been performed in cell culture media sup-
plemented with protein mixtures in varying composi-
tions, it is not surprising that apparently ‘identical’
studies in some cases yielded conflicting results.
The size ‒ as well the coating ‒ can also influence the
subcellular distribution of the internalized NPs. Lovrić et
al. [72] demonstrated that positively charged 5.2-nm
CdTe QDs were distributed throughout the cytoplasm
of N9 cells but did not enter the nucleus, whereas posi-
tively charged 2.2-nm QDs were localized predominantly
in the nuclear compartment. In contrast, Parak et al.
[73] found that the size of the silica-coated QDs (8 and
16 nm, functionalized with thiols, amines or mercapto-
propionic acid) did not influence the intracellular distri-
bution. Oh et al. [46] investigated the cellular uptake of
AuNPs coated with a cell-penetrating peptide. They re-
ported that the ultimate intracellular destination was
governed by the AuNP diameter. While the smallest,
2.4-nm AuNPs were found to localize to the nucleus,
intermediate, 5.5- and 8.2-nm particles remained seques-
tered within the endolysosomal system. The 16-nm and
larger AuNPs did not enter the cells on the experimental
time scale, which is at variance with other reports (see
Table 2).These few examples already show the wide range of
conclusions that can be drawn from NP uptake data. A
dependence on one particular physicochemical param-
eter, e.g., the core material of a core-shell NP, can be
measured only if all other parameters are kept constant.
There are only a few studies so far where this rule was
strictly obeyed.
NP size effects on passive uptake
Red blood cells (RBCs) lack a cell nucleus, most organelles
and, most importantly, the endocytic machinery [74].
Therefore, they have become valuable as a model system to
investigate passive NP uptake. In 2005, Geiser et al. [75] an-
alyzed the uptake of PS-NPs by RBCs and found that <200-
nm but not 1-μm NPs enter RBCs. Rothen-Rutishauser and
coworkers [76] refined the study and exposed RBCs to NPs
of different material, size and surface charge (Table 3), and
visualized them inside RBCs using confocal laser scanning
microscopy (CLSM) in combination with digital data res-
toration, conventional TEM, and energy filtering TEM. A
quantitative analysis revealed that only the size determined
the uptake efficiency. They confirmed that particles
<200 nm enter RBCs. The overall numbers were extremely
small, however, with less than 1 particle per cell on average.
Zhao et al. [79] investigated the interactions of meso-
porous silica nanoparticles (MSNs) having different sizes
and surface properties with RBC membranes using
membrane filtration, flow cytometry, and various micro-
scopic techniques to evaluate their potential for intra-
venous drug delivery. The study focused on the first step
of NP uptake, i.e., the interaction of the NPs with the
cell membrane. Small MCM-41-type MSNs (∼100 nm)
Table 3 Size dependence of passive cellular NP uptake
NPs Size (nm Ø) Bio-system Techniques Main conclusions Ref
DPA-
QDs
8 RBCs CLSM, SEIRAS QDs penetrate cell membranes without pore formation [77]
MSNs 100–300 RBCs TEM Hemolytic properties of MSNs related to silanol groups accessible to the cell
membranes
[78]
MSNs 100–600 RBCs CLSM, TEM Strongly dependent on surface chemistry and NP size [79]
PS 78–2,000 RBCs CLSM NPs < 0.2 μm enter RBCs [75]
PS 2–1,000 RBCs CLSM, TEM Surface charge and NP composition do not influence entry, NPs < 0.2 μm enter
RBCs, size is key factor for internalization by RBCs
[76]
Au 25–1,000
TiO2 20–30
HAP 14–175 RBCs Optical
microscopy,
TEM
Surface charge more crucial than the size for NP-RBC interaction, NP adhesion
led to invaginations on RBC membrane
[80]
Au 4–5 DC2.4 STM, CLSM ‘Striped’ NPs, decorated with alternating hydrophobic and hydrophilic ligands,
penetrate cell membranes without generating transient holes
[81]
Abbreviations used: SEIRAS surface-enhanced infrared absorption spectroscopy, HAP hydroxyapatite.
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membrane or the cell morphology (Figure 3). In con-
trast, adsorption of large SBA-15-type MSNs (∼600 nm)
induced strong local membrane deformations, followed
by internalization of the particles and, eventually,
hemolysis. The interactions of MSNs with the RBC
membranes apparently depended on the presence of sila-
nol groups on the particle surface because blocking
these silanols with organic groups reduced their interac-
tions with the RBC membranes.Figure 3 Passive NP uptake by red blood cells. (a – d) Internalization o
RBCs (5% hematocrit) incubated with 100 μg mL–1 of (e – h) small (~100 n
Reproduced with permission from the American Chemical Society.Recently, Wang et al. [77] studied the interactions be-
tween 8-nm QDs coated with the small, zwitterionic
amino acid ligand D-penicillamine (DPA) and RBCs. At
neutral pH, the charges on the amino and carboxylic
acid groups of the surface ligands are balanced. After in-
cubation with 10 nM DPA-QDs in PBS solution for dif-
ferent time periods and separation of free DPA-QDs by
centrifugation, the RBC cells were transferred to a
microscope sample cell and imaged using confocal fluor-
escence microscopy. The data clearly showed that thef DPA-QDs (8 nm) [77]. (e – l) Scanning electron micrographs (SEM) of
m) and (i – l) large (~600 nm) mesoporous silica particles (MSN) [79].
Shang et al. Journal of Nanobiotechnology 2014, 12:5 Page 7 of 11
http://www.jnanobiotechnology.com/content/12/1/5DPA-QDs adhered to the RBC membranes, and the
number of fluorescence spots, either close to the cell
membranes or inside the cells, increased with exposure
time (Figure 3). Moreover, the adsorbed DPA-QDs did
not induce strong local membrane deformations. In fact,
the RBC membranes remained largely intact during NP
penetration of the bilayer, as evidenced by confocal mi-
croscopy images taken in the presence of calcein violet
AM. This cell membrane-permeant dye becomes imper-
meant after entering the cell because of hydrolysis by
intracellular esterases [81]. Surface-enhanced infrared
absorption spectroscopy (SEIRAS) measurements car-
ried out on model membrane preparations resembling
RBC membranes revealed that the bilayer structure was
softened in the presence of DPA-QDs, which may facili-
tate penetration of DPA-QDs into the lipid bilayer with-
out causing poration.
The interaction of the NP with the membrane is argu-
ably the most critical step in passive membrane penetra-
tion. Van Lehn et al. [82] proposed that, to avoid pore
formation, the interaction should lead to fusion of the
NP with the membrane. They suggested that fusion is
highly favored when the ligand layer on the NP is able
to easily fluctuate to adjust to the membrane, allowingFigure 4 Cytotoxic effects of NPs. In the biological environment, NPs ma
ROS levels may lead to (i) activation of cellular stress-dependent signaling p
mitochondria and (iii) DNA fragmentation in the nucleus, resulting in cell c
with membrane-bound cellular receptors, e.g., growth factor (GF) receptors
apoptosis, differentiation, and migration. After internalization via endocytic
vesicles with the help of motor proteins and cytoskeletal structures. To acc
endolysosomal network and traverse through the crowded cytoplasm.surface charges to rearrange so that the NP appears lo-
cally hydrophobic. As the ligand layer around smaller
particles contains a large amount of free volume because
of the high curvature, ligand fluctuations are maximized
so that small NPs should more easily penetrate a mem-
brane. Certain small peptides [83,84] and synthetic
nanomaterials such as carbon nanotubes [85] were
found to be capable of crossing membranes without
poration. The DPA monolayer of the QDs used by Wang
et al. [77] resembles the pattern of hydrophobic and
charged residues found in cell-penetrating peptides.
Charged particles such as cationic QDs, however, typic-
ally induce transient poration of the cell membranes,
which may result in cytotoxic effects [81].
NP size affects cytotoxicity upon internalization
A complete analysis of the pharmacokinetics of NPs has to
include absorption of biomolecules, distribution, metabol-
ism, and excretion [86]. A protein adsorption layer on the
surface confers a new biological identity to the NP, which
may completely modify the subsequent cellular and tissue
responses, e.g., the distribution to various organs, tissues,
and cells. Once inside a cell or tissue, the surface layer, in-
cluding the adsorbed biomolecules, and also the NP corey trigger the production of reactive oxygen species (ROS). Elevated
athways, (ii) direct damage of subcellular organelles such as
ycle arrest, apoptosis, and inflammatory response. NPs may interact
and integrins, inducing cellular phenotypes such as proliferation,
pathways, NPs are trafficked along the endolysosomal network within
ess cytoplasmic or nuclear targets, NPs must escape from the
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nants of the) NPs may be excreted by the organism. All
these interactions with the biological environment are again
dependent on the physicochemical properties of NPs in-
cluding their size [87] (Figure 4). To evaluate the toxicity
profile of NPs, two main approaches have been established:
(i) functional assays assess the effects of NPs on cellular
processes, (ii) viability assays probe whether the NPs cause
death in a cell or a system of cells [88]. Although some as-
pects of size dependent NP toxicity may be reasonably well
predicted by in vitro techniques, it remains difficult to judge
whether the observed cytotoxicity is clinically relevant.
As can be inferred from the studies listed in Table 4,
smaller NPs appear to be more toxic than larger ones.
Small NPs possess a high surface area relative to their
total mass, which increases the chance to interact with
surrounding biomolecules and, as a consequence, to
trigger adverse responses. Pan et al. [89] observed that
small AuNPs (1.4 nm) were highly toxic and caused pre-
dominately rapid cell death by necrosis within 12 h,
while larger, 15-nm AuNPs displayed low toxicity, irre-
spective of cell type and surface ligands. Likewise, 4-nm
AgNPs were found to induce much higher levels ROS
production and interleukin-8 secretion than 20- and 70-
nm AgNPs at otherwise identical conditions [90]. A size
dependent toxicity was also reported for SiO2 [91] andTable 4 Size-dependent cytotoxicity of NPs
NPs Size
(nm, Ø)
Cell lines Evaluation techniques
Au 0.8–15 SK-MEL-28, HeLa,
L929, J774A1
TEM, MTT assays, FACS
QDs 2.2, 5.2 PC12, N9 MTT assays
Au 5, 15 Balb/3 T3 Colony forming efficiency, Trypan Bl
Au 3–38 J774 A1 Sizing and counting of cells
Ag 3–25
Au 10–25 HDMEC, A549,
NCIH441
MTS assays, Ki-67 expression, LDH re
Ag 15–55 F-12 K MTT assays, LDH leakage, ROS produ
inflammatory response
Ag 4–70 U937 Cell viability, ROS production, cytokin
SiO2 32, 83 Caco-2 WST-1 assays, comet assays
polymer 45, 90 NR8383, Caco-2 Mitochondrial membrane potential,
ATP depletion, TNF-α release
Ag 10–100 MC3T3, PC12 Cell viability, ROS production, LDH re
gene expression, apoptosis detection
TiO2 14–196 osteoblasts, L-02,
HEK 293
Alkaline phosphatase and zymograp
Au 20, 200 DU-145 MTS assays
SiO2 50, 200 GT1-7 Counting cells, intracellular calcium h
Abbreviations used: MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromid
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazoli
potential, WST water-soluble tetrazolium salt.polymer NPs [92]. In contrast, the immunological re-
sponses of macrophages to AgNPs in the size range 3–
25 nm were not significantly different, as inferred from
the expression of the pro-inflammatory gene products
interleukin-1, interleukin-6, and tumor necrosis factor
[93]. Chen et al. [94] reported that Au NPs of 3, 5, 50,
and 100 nm were nontoxic when injected intraperitone-
ally into mice, whereas Au NPs between 8 and 37 nm
caused severe toxicity and death within 3 weeks. In
HeLa cells, however, the same set of AuNPs was essen-
tially non-toxic, regardless of size. The toxic effects in
mice were less pronounced after coating the NP surface
with peptides that induced an enhanced immune re-
sponse. These apparently contradicting observations
stress that caution is advised when it comes to drawing
general conclusions on the in-vivo toxicity of a particular
NP preparation from in-vitro data. In fact, the condi-
tions under which nano-bio interactions take place in
living organisms such as experimental mammals or
humans are much more complex.
In summary, small NPs have a large, often catalytically
active surface that may favor adverse chemical reactions
such as ROS generation. Endocytosis mechanism, cellu-
lar uptake yield and efficiency of particle processing in
the endocytic pathway also depend on the NP size [87].
In whole organisms, e.g., mice, the in-vivo NP toxicity isMain conclusions Ref
Cytotoxicity depends on size, not ligand
chemistry; small NPs more toxic
[89]
Smaller NPs more toxic [72]
ue assays 5 nm, toxic; 15 nm, non-toxic [95]
AuNPs, increased toxicity for larger NPs; AgNPs,
no size-dependence in toxicity
[93]
lease Size not a significant factor for cytotoxicity
compared with surface ligands
[96]
ction, MMP, Increased toxicity for smaller NPs [97]
e release assays Size-dependent toxicity (4 nm highest) [90]
No cytotoxicity detected for either size [55]
ROS production, Positively charged 45-nm NPs more toxic than
equally charged 90-nm NPs
[92]
lease assays, 10 nm: greatest amount of apoptosis [98]
hy evaluation Size-dependent cytotoxicity, 100 nm critical size [99]
Both sizes cytotoxic [100]
omeostasis 200 nm: no toxic effects, 50 nm: toxicity with
Ca level increase
[91]
e, FACS fluorescence-activated cell sorting, LDH lactate dehydrogenase, MTS (3-
um) tetrazolium, ROS Reactive Oxygen Species, MMP mitochondrial membrane
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http://www.jnanobiotechnology.com/content/12/1/5directly related to the biodistribution and the retention
times, which are both size-dependent. Overall, the
harmfulness of NPs may closely correlate with their
size-related ability to readily enter biological systems.
However, size is not the only factor that governs tox-
icity; other factors such as surface functionalization also
play important roles. For example, cationic NPs are con-
sidered more toxic than neutral or anionic ones, pos-
sibly due to their high affinity towards the negatively
charged plasma membrane. Therefore, NP toxicity must
be evaluated by changing NP properties systematically,
one at a time.Conclusions
In summary, the size of NPs has a strong effect on their
interactions with living cells, influencing uptake effi-
ciency, internalization pathway selection, intracellular
localization and cytotoxicity. Despite huge efforts in this
area, it still remains challenging to reliably correlate a
particular cellular response with NP size. Considering
the vast variety of nanomaterials and the complexity of
the biological probes, it is difficult to draw general con-
clusions from the huge pool of available data. Still, we
believe that there are a few general trends that can be
trusted. (i) There is an optimal size for efficient endo-
cytosis of NPs independent of the particle composition.
(ii) This critical size can vary with cell type and surface
properties of the NPs. (iii) Small NPs have a higher
probability to be internalized by passive uptake than
large ones. (iv) Under otherwise identical conditions,
small NPs are more likely to cause toxic cellular
responses.
Further research on NP-cell interactions will benefit
from advances in the synthesis of well-defined, monodis-
perse NPs and the development of sophisticated analysis
tools. We are confident that these efforts will result in a
better understanding of the influence of physicochemical
properties of nanomaterials on their interaction with
biological systems and will provide guidelines to the de-
sign of more advanced biocompatible and efficient
nanodevices.
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